BMP9 signaling promotes the normalization of tumor blood vessels-Reference-Cited by-同舟云学术

BMP9 signaling promotes the normalization of tumor blood vessels

Published:2020-02-10 Issue:14 Volume:39 Page:2996-3014
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Viallard Claire,Audiger Cindy,Popovic Natalija,Akla Naoufal,Lanthier Kevin,Legault-Navarrete Isaac,Melichar Heather,Costantino Santiago,Lesage Sylvie^ORCID,Larrivée Bruno

Funder

Fonds de Recherche du Québec - Santé

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-1200-0.pdf

Reference84 articles.

1. Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20:409–26.

2. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88–91.

3. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58–62.

4. Greenberg JI, Cheresh DA. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Exp Opin Biol Ther. 2009;9:1347–56.

5. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10:417–27.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Genes ingenuity pathway analysis unveils smoothelin‐like 1 (SMTNL1) as a key regulatory protein involved in sodium pentobarbital‐induced growth inhibition in breast cancer;Pharmacology Research & Perspectives;2023-11-09

3. TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors;Cancer Biology & Medicine;2023-11-02

4. Alleviating hypoxia to improve cancer immunotherapy;Oncogene;2023-10-26

5. Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug;iScience;2023-09